This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Furosemide Injection USP (2015-05-22)

Starting date:
May 22, 2015
Posting date:
May 26, 2015
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-53549

Recalled Products

Furosemide Injection USP

Reason

One lot (lot number: 30208) of Furosemide Injection USP 10 mg/mL (DIN 02384094) marketed and sold by Alveda Pharmaceuticals Inc. is being recalled, due to an incorrect barcode on the ampoule label. The barcode reads (01)00837641000591 which is the same barcode as on the ampoule label of Alveda Epinephrine Injection USP 1 mg/mL (DIN 02325225). Epinephrine is not being recalled so as not to precipitate a shortage.

Depth of distribution

Hospitals and pharmacies

Affected products

Furosemide Injection USP

DIN, NPN, DIN-HIM
DIN 02384094
Dosage form

Solution

Strength

Furosemide 10 mg/mL

Lot or serial number

30208

Companies
Recalling Firm
Alveda Pharmaceutical Inc.
Suite 1100, 21 St. Clair Avenue East,
Toronto
M4T 1L9
Ontario
CANADA
Marketing Authorization Holder
Alveda Pharmaceutical Inc.
Suite 1100, 21 St. Clair Avenue East,
Toronto
M4T 1L9
Ontario
CANADA

Date modified: